High- and Low-Load Resistance Training
1 other identifier
interventional
22
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether low-load resistance training performed to muscle failure can produce similar increases in muscle size and strength as high-load resistance training in healthy untrained young adult males. The main questions it aims to answer are: Does low-load resistance training (30% of one-repetition maximum) performed to failure increase muscle strength and muscle size to a similar extent as high-load resistance training (75% of one-repetition maximum)? Are there differences in total training volume between low-load and high-load resistance training programs performed to failure? Researchers will compare a low-load resistance training group to a high-load resistance training group to determine whether the magnitude of changes in muscle strength and hypertrophy differs between the two approaches. Participants will: Be randomly assigned to either a low-load (30% 1RM) or high-load (75% 1RM) resistance training group Perform supervised leg extension exercises to the point of voluntary muscle fatigue three times per week for 6 weeks Complete muscle strength testing (one-repetition maximum) before and after the training period Undergo ultrasound measurements to assess muscle thickness and cross-sectional area of thigh muscles before and after the intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2022
CompletedFirst Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedFebruary 18, 2026
February 1, 2026
6 months
February 9, 2026
February 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Maximal Dynamic Strength - Estimated One-Repetition Maximum (1RM) Using Submaximal Prediction and Epley Equation
Maximal strength will be estimated using a submaximal 1RM prediction protocol (8-10 repetitions) following a standardized warm-up. The highest load completed within the target repetition range will be used to calculate 1RM using the Epley equation (1RM = Load × \[1 + 0.033 × repetitions\]). Results will be expressed in kilograms (kg), with higher values indicating greater strength. Assessed at baseline and Week 4.
Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)
Muscle Thickness (MT) and Cross-Sectional Area (CSA) - Assessed by B-Mode Ultrasonography (LOGIQ S8, GE Healthcare)
Muscle thickness (cm) and cross-sectional area (cm²) of the rectus femoris and vastus intermedius will be assessed using B-mode ultrasonography (LOGIQ S8, GE Healthcare, 2-8 MHz linear probe). Three images per site will be averaged for analysis. Higher values indicate greater muscle hypertrophy. Measurements performed at baseline and post-intervention by a blinded assessor.
Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)
Secondary Outcomes (1)
Muscular Endurance - Repetitions to Volitional Failure at 50% of Estimated 1RM
Baseline (Week 0) and immediately after completion of the 6-week intervention (Week 6)
Study Arms (2)
LLRT
EXPERIMENTALHLRT
EXPERIMENTALInterventions
Participants perform unilateral or bilateral leg extension exercise at 30% of their individually determined one-repetition maximum (1RM). Each training session consists of sets performed to volitional muscular failure. Training is conducted three times per week for 6 weeks under direct supervision. Load is adjusted if necessary to maintain the target relative intensity. All repetitions are performed using a controlled movement tempo.
Participants perform the same leg extension exercise at 75% of their individually determined one-repetition maximum (1RM). As in the LLRT group, sets are performed to volitional muscular failure. Training frequency (three sessions per week), duration (6 weeks), supervision, exercise selection, and movement tempo are identical to the LLRT group.
Eligibility Criteria
You may qualify if:
- Male sex
- Age between 18 and 28 years
- Healthy status as determined by self-report health screening
- No participation in structured resistance training or lower-limb power training within the previous 12 months
- Engaging only in recreational physical activity (no systematic lower-body resistance training)
- Willingness to maintain usual daily routines throughout the study period
- Agreement to refrain from any structured lower-body resistance training during the 6-week intervention
- Provision of written informed consent
You may not qualify if:
- Any current or recent musculoskeletal injury affecting lower-limb function
- History or presence of cardiovascular disease
- History or presence of metabolic disorders
- Resting hypertension (≥140/90 mmHg)
- Regular tobacco use
- Use of medications known to affect neuromuscular performance
- Inability or unwillingness to comply with the training protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Akdeniz Universitylead
- Selcuk Universitycollaborator
Study Sites (1)
Selcuk University
Meram, Konya, 04204, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 17, 2026
Study Start
December 18, 2021
Primary Completion
June 20, 2022
Study Completion
July 2, 2022
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share